Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

European Journal of Endocrinology

Volumn 170, Issue 4, 2014, Pages 529-538

  Bak, Monika J ^a,b   Albrechtsen, Nicolai Wewer ^a   Pedersen, Jens ^a   Hartmann, Bolette ^a   Christensen, Mikkel ^c   Vilsbøll, Tina ^c   Knop, Filip K ^c   Deacon, Carolyn F ^a   Dragsted, Lars O ^b   Holst, Jens J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLICENTIN; GLUCAGON; OXYNTOMODULIN; PROGLUCAGON;

ACCURACY; AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCAGON; HUMANS; OXYNTOMODULIN; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

EID: 84899492680     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0941     Document Type: Article

References (24)

1. Bell GI, Santerre RF & Mullenbach GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 1983 302 716-718. (doi:10.1038/302716a0)
2. Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B & Orskov C. Proglucagon processing in porcine and human pancreas. Journal of Biological Chemistry 1994 269 18827-18833.
3. Rouille Y, Westermark G, Martin SK & Steiner DF. Proglucagon is processed to glucagon by prohormone convertase PC2 in a TC1-6 cells. PNAS 1994 91 3242-3246. (doi:10.1073/pnas.91.8.3242)
4. Holst JJ. Gut glucagon, enteroglucagon, gut glucagon-like immunoreactivity, glicentin-current status. Gastroenterology 1983 84 1602-1613.
5. Ugleholdt R, Zhu X, Deacon CF, Orskov C, Steiner DF & Holst JJ. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1. Endocrinology 2004 145 1349-1355. (doi:10.1210/en. 2003-0801)
6. Baldissera FG & Holst JJ. Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 1984 26 223-228. (doi:10.1007/BF00252412)
7. Holst JJ. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochemical Journal 1982 207 381-388.
8. Brand CL, Jorgensen PN, Svendsen I & Holst JJ. Evidence for a major role for glucagon in regulation of plasma glucose in conscious, nondiabetic, and alloxan-induced diabetic rabbits. Diabetes 1996 45 1076-1083. (doi:10.2337/diab.45.8.1076)
9. Holst JJ. The physiology of glucagon-like peptide 1. Physiological Reviews 2007 87 1409-1439. (doi:10.1152/physrev. 00034.2006)
10. Orskov C, Holst J, Knuthsen S, Baldiserra F, Poulsen S & Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 1986 119 1467-1475. (doi:10.1210/endo-119-4-1467)
11. Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L & Habener JF. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Journal of Biological Chemistry 1986 261 11880-11889.
12. Muller WA, Faloona GR, Aguilar-Parada E & Unger RH. Abnormal a-cell function in diabetes. Response to carbohydrate and protein ingestion. New England Journal of Medicine 1970 283 109-115. (doi:10.1056/NEJM197007162830301)
13. Friis-Hansen L, Lacourse KA, Samuelson LC & Holst JJ. Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice. Journal of Endocrinology 2001 169 595-602. (doi:10.1677/joe.0.1690595)
14. Unger RH, Aguilar-Parada E, Muller WA & Eisentraut AM. Studies of pancreatic a cell function in normal and diabetic subjects. Journal of Clinical Investigation 1970 49 837-848. (doi:10.1172/JCI106297)
15. Toft-Nielsen MB, Madsbad S & Holst JJ. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2001 86 3853-3860.
16. Ohneda A & Ohneda M. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas. Tohoku Journal of Experimental Medicine 1988 155 197-204. (doi:10.1620/tjem. 155.197)
17. Kirkegaard P, Moody AJ, Holst JJ, Loud FB, Olsen PS & Christiansen J. Glicentin inhibits gastric acid secretion in the rat. Nature 1982 297 156-157. (doi:10.1038/297156a0)
18. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA & Bloom SR. Oxyntomodulin suppresses appetite and reduces food intake in humans. Journal of Clinical Endocrinology and Metabolism 2003 88 4696-4701. (doi:10.1210/jc.2003-030421)
19. Baldissera FG, Holst JJ, Knuhtsen S, Hilsted L & Nielsen OV. Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs. Regulatory Peptides 1988 21 151-166. (doi:10.1016/0167-0115 (88) 90099-7)
20. Vrang N & Larsen PJ. Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides. Progress in Neurobiology 2010 92 442-462. (doi:10.1016/j.pneurobio. 2010.07.003)
21. Baldissera FG & Holst JJ. Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs. Diabetologia 1986 29 462-467. (doi:10.1007/BF00506540)
22. Holst JJ. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours. Diabetologia 1983 24 359-365.
23. Holst JJ. Evidence that glicentin contains the entire sequence of glucagon. Biochemical Journal 1980 187 337-343.
24. Christensen M, Vedtofte L, Holst JJ, Vilsboll T & Knop FK. Glucosedependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans. Diabetes 2011 60 3103-3109. (doi:10.2337/db11-0979)